Claiming Trasylol a Defective Drug ~ OPOLAW Injury Blog

Wednesday, January 28, 2009

Claiming Trasylol a Defective Drug

A complaint has been filed against Bayer Corporation and its parent company, Bayer AG on behalf of Ada M. Williams for the defective drug, Trasylol. “Ms. Williams allegedly suffered permanent kidney damage after being given Trasylol®---a Bayer-manufactured drug given to patients during open-heart surgery to prevent the potential for excessive bleeding as a result of the surgery.” During open-heart surgery, Ms. Williams went into kidney failure and is now required to undergo kidney dialysis three days a week for the rest of her life, as a result of being given Trasylol. An article in the Journal of the American Medical Association stated that the long-term effects to patients given Trasylol during open-heart surgery is associated with an increased risk of death during the first five years after the surgery. Additionally, a study published in The New England Journal of Medicine in January 2006 revealed that Trasylol doubled the risk of kidney failure in patients given Trasylol during open-heart surgery.

No comments:

Post a Comment